
E43: Innovative venture strategies, Zymergen's implosion, Square acquires Afterpay & more
TL;DR
- Friedberg's Production Board raised $300 million backed by Alphabet, and Sacks launched a new $1.1 billion SaaS-focused fund called Craft III
- Discussion of innovative venture strategies including internal markups, venture studios, and deployment tactics for maximizing capital efficiency
- Zymergen's dramatic collapse after announcing immaterial revenue projections, highlighting failures in due diligence and the challenges of scaling deep tech
- Panel shares lessons from fraudulent companies like Theranos and Nikola, emphasizing the importance of recognizing red flags in founder narratives
- Square's acquisition of Afterpay represents a strategic fintech consolidation move in a shifting landscape of financial regulation and deplatforming
- The besties debut a new track called the Friedberg Index, celebrating the week's major venture announcements
Episode Recap
This episode features the all-in podcast panel discussing major venture capital moves and recent startup implosions shaping the technology and business landscape. The conversation opens with celebration of significant wins for panel members, including David Friedberg's Production Board securing $300 million in funding backed by Alphabet's Larry Page and David Sacks announcing Craft III, a new venture fund with $1.1 billion for SaaS companies and marketplaces. These announcements exemplify the scale and momentum in venture capital markets during this period.
The panel then pivots to discussing innovative venture strategies that go beyond traditional fund structures. They explore internal markups, venture studios, and various deployment strategies that venture firms use to maximize returns and accelerate company growth. These structural innovations reflect how the venture industry is evolving to manage capital more effectively and create additional value beyond passive investment.
A significant portion of the episode focuses on Zymergen's catastrophic implosion, where the synthetic biology company saw its stock plunge 68% after announcing that product revenue would be immaterial in 2022. The panel dissects the role of due diligence failures and discusses the fundamental challenges of scaling deep technology companies. They explore how promising early narratives can mask operational reality and how investors sometimes overlook red flags in their enthusiasm for transformative technologies.
The conversation deepens when Chamath and Jason share firsthand stories from their experience with Theranos, offering insights into how fraudulent companies operate and maintain investor confidence despite fundamental problems. Jason Calacanis highlights his efforts to call out fraudulent behavior and the importance of skepticism in venture investing. The panel discusses how personal risk perception impacts decision-making at scale and how compelling narratives can drive fundraising success even when underlying business fundamentals are questionable.
Financial deplatforming and fintech consolidation receive significant attention as the panel analyzes Square's acquisition of Afterpay. They discuss what this move reveals about the evolving fintech landscape, regulatory pressures on financial services, and Jack Dorsey's unique position of power in the industry. The acquisition is positioned as a savvy strategic move that addresses market consolidation and changing regulatory environments.
Throughout the episode, the panel demonstrates the interconnected nature of venture capital, startup success and failure, regulatory pressures, and founder accountability. They balance celebrating wins with critical analysis of industry failures, emphasizing that due diligence, founder integrity, and honest assessment of business fundamentals remain crucial to sustainable venture investing. The episode concludes with the panel celebrating their discussion through a new song called the Friedberg Index, maintaining the show's characteristic blend of serious business analysis and humor.
Key Moments
Notable Quotes
“The narrative matters just as much as the business fundamentals when it comes to fundraising”
“Due diligence failures allowed companies like Zymergen and Theranos to persist longer than they should have”
“Venture studios and internal markups represent the next evolution in how capital is deployed efficiently”
“Jack Dorsey's position in fintech gives Square a unique strategic advantage in navigating regulatory changes”
“Red flags in founder behavior and company metrics are often ignored because investors want to believe in the story”


